Novartis Ag (NVS) Q4 2022 Earnings Call Transcript

NVS earnings call for the period ending December 31, 2022.

Related Keywords

Germany ,Japan ,United States ,Zaragoza ,Baja California ,Mexico ,China ,Italy ,Melbourne ,Victoria ,Australia ,San Antonio ,Texas ,Switzerland ,France ,Spain ,Italian ,German ,Swiss ,Graham Parry ,Richard Parkes ,Matthew Weston ,Andrew Baum ,Tim Anderson ,Societe Generale ,Florent Cespedes ,Harry Kirsch ,Samir Shah ,Richard Parkes Exane ,Florent Cespedes Societe Generale ,Mark Purcell ,Simon Baker ,Andrew Baum Citi ,Emmanuel Papadakis ,Steve Scala Cowen ,Seamus Fernandez Guggenheim ,Steve Scala ,Simon Baker Redburn ,America Merrill Lynch ,Michael Leuchten ,Keyur Parekh Goldman Sachs ,Mark Purcell Morgan Stanley ,Peter Welford Jefferies ,Keyur Parekh ,Seamus Fernandez ,Richard Vosser Jpmorgan ,Peter Welford ,Richard Vosser ,Fiona Marshall ,Promacta Revolade ,Morgan Stanley ,Tim Anderson Wolfe Research Analyst ,European Commission ,Goldman Sachs ,Emmanuel Papadakis Deutsche Bank Analyst ,Credit Suisse ,Graham Parry Bank ,Deutsche Bank ,Novartis ,Exchange Commission ,Wolfe Research ,San Antonio Breast Cancer Congress ,Company Analyst ,Barclays ,Motley Fool Stock Advisor ,Stock Advisor ,Lupus Nephritis ,Latin America ,Middle East ,Innovative Medicines ,Ronny Steel ,Emily Field ,Cold Agglutinin Disease ,Guggenheim Partners ,Redburn Partners ,